Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a drug-coated balloon for treating blocked coronary arteries

Official title: Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention (IMAGINATION)

Run by National Institute of Cardiology, Warsaw, Poland · NCT06275386 · Data updated 2026-11-12

This study is testing whether a drug-coated balloon can safely help people with blocked coronary arteries feel better during a heart procedure.

More Coronary Artery Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorNational Institute of Cardiology, Warsaw, Poland
Academic / other
Locations1 site (Warsaw, Masovian Voivodeship)
StatusRecruiting
StartedMarch 24, 2024
Main results expectedDecember 31, 2025
Study endsMay 2026
Registry record updatedJanuary 2, 2026
Trial IDNCT06275386 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are symptomatic patients with a native chronic total occlusion who meet specific clinical criteria for PCI.

Probably not a fit

Patients with conditions such as myocardial infarction, severe valvular disease, or those who are not suitable for PCI will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The IMAGINATION trial is a prospective, single-center investigation focusing on symptomatic patients with chronic total occlusion (CTO) of coronary arteries. It aims to evaluate the efficacy and safety of a drug-coated balloon (DCB) during percutaneous coronary intervention (PCI) guided by intravascular ultrasound (IVUS). Patients will undergo baseline assessments and follow-up evaluations at 6 and 12 months to assess the outcomes of the DCB treatment. The study seeks to provide insights that could lead to future randomized trials comparing DCB to traditional drug-eluting stents.

Why it matters

Potential benefit: If successful, this approach could offer a safer and more effective treatment option for patients with chronic total occlusion of coronary arteries.

How similar studies have gone: While there have been advancements in CTO PCI techniques, the specific use of drug-coated balloons for this purpose is still being explored and has not been widely tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical indication for CTO PCI as determined by the local heart team (presence of angina or equivalent symptoms and/or documented ischemia or viability)
* native CTO lesion as defined by invasive coronary angiography
* informed consent for participation in the study

Exclusion Criteria:

* \<18 years of age
* myocardial infarction
* cardiogenic shock
* severe valvular disease
* estimated life expectancy \<1 year
* contraindication to PCI
* positive pregnancy test or breast-feeding
* in-stent CTO
* CTO recanalization using antegrade or retrograde dissection and re-entry techniques

Where it's running

  • National Institute of Cardiology
    Warsaw, Masovian Voivodeship, Poland
    Recruiting

Study contacts

  • Principal investigator: Maksymilian Opolski — National Institute of Cardiology
  • Study coordinator: Maksymilian Opolski
  • Email: mopolski@ikard.pl
  • Phone: 0048(22)3434127

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.